These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2018 and 2019. Barrow P, Clemann N. Reprod Toxicol; 2021 Jan; 99():144-151. PubMed ID: 32593570 [Abstract] [Full Text] [Related]
5. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023. Barrow P. Reprod Toxicol; 2024 Dec; 130():108727. PubMed ID: 39332698 [Abstract] [Full Text] [Related]
7. Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits. Patyna S, Haznedar J, Morris D, Freshwater K, Peng G, Sukbuntherng J, Chmielewski G, Matsumoto D. Birth Defects Res B Dev Reprod Toxicol; 2009 Jun; 86(3):204-13. PubMed ID: 19294680 [Abstract] [Full Text] [Related]
8. Evaluation of rat and rabbit embryofetal development studies with pharmaceuticals: the added value of a second species. Roos P, Anggasta C, Piersma AH, van Meer PJK, Theunissen PT. Crit Rev Toxicol; 2024 Oct; 54(9):619-633. PubMed ID: 39093553 [Abstract] [Full Text] [Related]
9. Comparing rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on systemic dose and developmental effects. Theunissen PT, Beken S, Beyer B, Breslin WJ, Cappon GD, Chen CL, Chmielewski G, de Schaepdrijver L, Enright B, Foreman JE, Harrouk W, Hew KW, Hoberman AM, Y Hui J, Knudsen TB, Laffan SB, Makris SL, Martin M, McNerney ME, Siezen CL, Stanislaus DJ, Stewart J, Thompson KE, Tornesi B, Van der Laan JW, Weinbauer GF, Wood S, Piersma AH. Crit Rev Toxicol; 2017 May; 47(5):402-414. PubMed ID: 27766926 [Abstract] [Full Text] [Related]
11. Tavaborole, a Novel Boron-Containing Small Molecule Pharmaceutical Agent for Topical Treatment of Onychomycosis: I. Reproductive and Developmental Toxicity Studies. Ciaravino V, Coronado D, Lanphear C, Hoberman A, Chanda S. Int J Toxicol; 2016 Sep; 35(5):530-42. PubMed ID: 27044640 [Abstract] [Full Text] [Related]
14. Exposure assessments in reproductive and developmental toxicity testing: An IQ-DruSafe industry survey on current practices and experiences in support of exposure-based high dose selection. Andrews PA, McNerney ME, DeGeorge JJ. Regul Toxicol Pharmacol; 2019 Oct; 107():104413. PubMed ID: 31229519 [Abstract] [Full Text] [Related]
19. Developmental Toxicity and Fertility Assessment in Rabbits with Tabalumab: A Human IgG4 Monoclonal Antibody. Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Edwards TL. Birth Defects Res B Dev Reprod Toxicol; 2015 Jun; 104(3):117-28. PubMed ID: 26195315 [Abstract] [Full Text] [Related]
20. Knockout mouse models are predictive of malformations or embryo-fetal death in drug safety evaluations. Catlin NR, Stethem CM, Bowman CJ, Campion SN, Nowland WS, Cappon GD. Reprod Toxicol; 2020 Sep; 96():11-16. PubMed ID: 32522587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]